Advanced

Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.

Lindahl, Bengt LU ; Persson, Jan LU ; Ranstam, Jonas LU and Willén, Roger (2010) In Anticancer Research 30(9). p.3727-3730
Abstract
Uterine clear cell carcinoma (UCC) and uterine papillary serous carcinoma (UPSC) are rare entities that differ in clinical behavior from endometrial adenocarcinoma. Compared with endometrioid adenocarcinoma, they more often metastasize early and more commonly in the upper abdomen including the omentum. Treatment programs of UCC and UPSC at different stages vary and range from no adjuvant therapy in stage Ia to a wide variety of chemotherapies and radiotherapies in more advanced stages. This study presents the outcome of 109 patients with UCC or UPSC treated according to essentially the same treatment program from May 1993 to December 2004. Most patients were treated with a simple hysterectomy with no further adjuvant treatment. In stage... (More)
Uterine clear cell carcinoma (UCC) and uterine papillary serous carcinoma (UPSC) are rare entities that differ in clinical behavior from endometrial adenocarcinoma. Compared with endometrioid adenocarcinoma, they more often metastasize early and more commonly in the upper abdomen including the omentum. Treatment programs of UCC and UPSC at different stages vary and range from no adjuvant therapy in stage Ia to a wide variety of chemotherapies and radiotherapies in more advanced stages. This study presents the outcome of 109 patients with UCC or UPSC treated according to essentially the same treatment program from May 1993 to December 2004. Most patients were treated with a simple hysterectomy with no further adjuvant treatment. In stage Ia, 2/46 patients died of their disease and amongst all the stages, 30/109 patients died of their disease. These survival outcomes are comparable to or better than those presented previously. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Anticancer Research
volume
30
issue
9
pages
3727 - 3730
publisher
International Institute of Cancer Research
external identifiers
  • wos:000283009400071
  • pmid:20944161
  • scopus:77958530195
ISSN
1791-7530
language
English
LU publication?
yes
id
9bb4320b-00e7-4157-b5e2-79231980218c (old id 1711199)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/20944161?dopt=Abstract
date added to LUP
2010-11-05 15:53:58
date last changed
2018-05-29 11:26:46
@article{9bb4320b-00e7-4157-b5e2-79231980218c,
  abstract     = {Uterine clear cell carcinoma (UCC) and uterine papillary serous carcinoma (UPSC) are rare entities that differ in clinical behavior from endometrial adenocarcinoma. Compared with endometrioid adenocarcinoma, they more often metastasize early and more commonly in the upper abdomen including the omentum. Treatment programs of UCC and UPSC at different stages vary and range from no adjuvant therapy in stage Ia to a wide variety of chemotherapies and radiotherapies in more advanced stages. This study presents the outcome of 109 patients with UCC or UPSC treated according to essentially the same treatment program from May 1993 to December 2004. Most patients were treated with a simple hysterectomy with no further adjuvant treatment. In stage Ia, 2/46 patients died of their disease and amongst all the stages, 30/109 patients died of their disease. These survival outcomes are comparable to or better than those presented previously.},
  author       = {Lindahl, Bengt and Persson, Jan and Ranstam, Jonas and Willén, Roger},
  issn         = {1791-7530},
  language     = {eng},
  number       = {9},
  pages        = {3727--3730},
  publisher    = {International Institute of Cancer Research},
  series       = {Anticancer Research},
  title        = {Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.},
  volume       = {30},
  year         = {2010},
}